Ishita Drugs and Industries Limited (BOM:524400)
India
· Delayed Price · Currency is INR 72.00
+4.40 (6.51%)
At close: Mar 9, 2026
BOM:524400 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Revenue | 161.68 | 149.97 | 151.88 | 120.72 | 140.9 | 139.49 | Upgrade
|
| Revenue Growth (YoY) | 8.30% | -1.25% | 25.80% | -14.32% | 1.01% | -5.96% | Upgrade
|
| Cost of Revenue | 135.33 | 126.13 | 129.37 | 100.12 | 118.14 | 119.29 | Upgrade
|
| Gross Profit | 26.36 | 23.85 | 22.5 | 20.6 | 22.76 | 20.2 | Upgrade
|
| Selling, General & Admin | 13.84 | 13.83 | 13.42 | 12.98 | 11.85 | 11.02 | Upgrade
|
| Other Operating Expenses | 2.89 | 0 | - | - | - | - | Upgrade
|
| Operating Expenses | 17.82 | 14.93 | 14.53 | 14.28 | 13.15 | 12.48 | Upgrade
|
| Operating Income | 8.54 | 8.92 | 7.97 | 6.32 | 9.61 | 7.72 | Upgrade
|
| Interest Expense | -0.47 | -0.35 | -0.62 | -0.37 | -0.04 | -0.19 | Upgrade
|
| Interest & Investment Income | 3.36 | 3.36 | 2.8 | 2.01 | 1.06 | 3.14 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.41 | -0.38 | -0.28 | -0.17 | -0.2 | -0.13 | Upgrade
|
| Pretax Income | 11.84 | 11.55 | 9.87 | 7.79 | 10.43 | 10.54 | Upgrade
|
| Income Tax Expense | 2.95 | 2.87 | 2.39 | 2.02 | 2.38 | 2.24 | Upgrade
|
| Net Income | 8.89 | 8.68 | 7.49 | 5.77 | 8.05 | 8.3 | Upgrade
|
| Net Income to Common | 8.89 | 8.68 | 7.49 | 5.77 | 8.05 | 8.3 | Upgrade
|
| Net Income Growth | 3.13% | 15.98% | 29.63% | -28.27% | -2.97% | 51.64% | Upgrade
|
| Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade
|
| EPS (Basic) | 2.97 | 2.90 | 2.50 | 1.93 | 2.69 | 2.77 | Upgrade
|
| EPS (Diluted) | 2.97 | 2.90 | 2.50 | 1.93 | 2.69 | 2.77 | Upgrade
|
| EPS Growth | 3.12% | 16.00% | 29.53% | -28.25% | -2.89% | 51.40% | Upgrade
|
| Free Cash Flow | - | -38.21 | 20.94 | -30.32 | 30.58 | -6.8 | Upgrade
|
| Free Cash Flow Per Share | - | -12.78 | 7.00 | -10.14 | 10.23 | -2.27 | Upgrade
|
| Gross Margin | 16.30% | 15.90% | 14.82% | 17.07% | 16.16% | 14.48% | Upgrade
|
| Operating Margin | 5.28% | 5.95% | 5.25% | 5.24% | 6.82% | 5.53% | Upgrade
|
| Profit Margin | 5.50% | 5.79% | 4.93% | 4.78% | 5.71% | 5.95% | Upgrade
|
| Free Cash Flow Margin | - | -25.48% | 13.79% | -25.11% | 21.70% | -4.87% | Upgrade
|
| EBITDA | 9.63 | 10.01 | 9.08 | 7.62 | 10.91 | 9.18 | Upgrade
|
| EBITDA Margin | 5.95% | 6.68% | 5.98% | 6.31% | 7.74% | 6.58% | Upgrade
|
| D&A For EBITDA | 1.08 | 1.1 | 1.12 | 1.29 | 1.3 | 1.46 | Upgrade
|
| EBIT | 8.54 | 8.92 | 7.97 | 6.32 | 9.61 | 7.72 | Upgrade
|
| EBIT Margin | 5.28% | 5.95% | 5.25% | 5.24% | 6.82% | 5.53% | Upgrade
|
| Effective Tax Rate | 24.89% | 24.85% | 24.18% | 25.92% | 22.82% | 21.27% | Upgrade
|
| Revenue as Reported | 165.83 | 153.33 | 154.68 | 122.73 | 141.97 | 142.63 | Upgrade
|
| Advertising Expenses | - | 0.02 | 0.02 | 0.15 | 0.04 | 0.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.